VHH Antibodies: Small Size. Big Possibilities.

by Biotech Newsroom


View eBook

This guide shows how single-domain antibodies can unlock crypitic epitopes, streamline CAR-T design, and sepped up the path to multispecific biologics.

Why VHH matters today

VHH Antibodies: Small Size. Big Possibilities. eBook CoverCamelid single-domain antibodies pack high affinity and exceptional stability into a footprint of about fifteen kilodaltons. They reach grooves that full IgGs cannot, tolerate harsh process conditions, and lend themselves to rapid genetic fusion.

Over the past decade VHH binders have moved from laboratory curiosity to clinical reality,…



Source link

You may also like

Houston, TX – (EmailWire) — The Biotech Times™ aggregates, publishes and distributes news about the Biotech Industry. In association with EmailWire™, The Biotech Times, helps businesses and organizations in the industry with press release distribution. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:

Free Magazines

Recent Articles

BioTech Times™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC